BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4
12 results:

  • 1. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
    Huang G; Zhang X; Xu Y; Chen S; Cao Q; Liu W; Fu Y; Jia Q; Shen J; Yin J; Zhang J
    J Transl Med; 2024 Jan; 22(1):88. PubMed ID: 38254188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (tcf7l2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway.
    Park M; Cho YJ; Kim B; Ko YJ; Jang Y; Moon YH; Hyun H; Lim W
    Sci Rep; 2021 Jun; 11(1):12186. PubMed ID: 34108600
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
    Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
    Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium.
    Ng MCY; Graff M; Lu Y; Justice AE; Mudgal P; Liu CT; Young K; Yanek LR; Feitosa MF; Wojczynski MK; Rand K; Brody JA; Cade BE; Dimitrov L; Duan Q; Guo X; Lange LA; Nalls MA; Okut H; Tajuddin SM; Tayo BO; Vedantam S; Bradfield JP; Chen G; Chen WM; Chesi A; Irvin MR; Padhukasahasram B; Smith JA; Zheng W; Allison MA; Ambrosone CB; Bandera EV; Bartz TM; Berndt SI; Bernstein L; Blot WJ; Bottinger EP; Carpten J; Chanock SJ; Chen YI; Conti DV; Cooper RS; Fornage M; Freedman BI; Garcia M; Goodman PJ; Hsu YH; Hu J; Huff CD; Ingles SA; John EM; Kittles R; Klein E; Li J; McKnight B; Nayak U; Nemesure B; Ogunniyi A; Olshan A; Press MF; Rohde R; Rybicki BA; Salako B; Sanderson M; Shao Y; Siscovick DS; Stanford JL; Stevens VL; Stram A; Strom SS; Vaidya D; Witte JS; Yao J; Zhu X; Ziegler RG; Zonderman AB; Adeyemo A; Ambs S; Cushman M; Faul JD; Hakonarson H; Levin AM; Nathanson KL; Ware EB; Weir DR; Zhao W; Zhi D; ; Arnett DK; Grant SFA; Kardia SLR; Oloapde OI; Rao DC; Rotimi CN; Sale MM; Williams LK; Zemel BS; Becker DM; Borecki IB; Evans MK; Harris TB; Hirschhorn JN; Li Y; Patel SR; Psaty BM; Rotter JI; Wilson JG; Bowden DW; Cupples LA; Haiman CA; Loos RJF; North KE
    PLoS Genet; 2017 Apr; 13(4):e1006719. PubMed ID: 28430825
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]    [Full Text] [Related]  

  • 7. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.
    González N; Prieto I; Del Puerto-Nevado L; Portal-Nuñez S; Ardura JA; Corton M; Fernández-Fernández B; Aguilera O; Gomez-Guerrero C; Mas S; Moreno JA; Ruiz-Ortega M; Sanz AB; Sanchez-Niño MD; Rojo F; Vivanco F; Esbrit P; Ayuso C; Alvarez-Llamas G; Egido J; García-Foncillas J; Ortiz A;
    Oncotarget; 2017 Mar; 8(11):18456-18485. PubMed ID: 28060743
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
    Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
    Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and tcf7l2 binding.
    Lewis A; Freeman-Mills L; de la Calle-Mustienes E; Giráldez-Pérez RM; Davis H; Jaeger E; Becker M; Hubner NC; Nguyen LN; Zeron-Medina J; Bond G; Stunnenberg HG; Carvajal JJ; Gomez-Skarmeta JL; Leedham S; Tomlinson I
    Cell Rep; 2014 Aug; 8(4):983-90. PubMed ID: 25131200
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
    De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT
    Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis.
    Døsen G; Tenstad E; Nygren MK; Stubberud H; Funderud S; Rian E
    BMC Immunol; 2006 Jun; 7():13. PubMed ID: 16808837
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Influence of MRI abnormality in skull base bone on prognosis of nasopharyngeal carcinoma.
    Lu JC; Wei Q; Zhang YQ; Li F
    Cancer Radiother; 2004 Aug; 8(4):230-3. PubMed ID: 15450516
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.